Officer Background

Bill Kolek and Bob Catuosco, senior officers, have a combined 35 years of expertise in the pain management discipline. Bill and Bob were previous employees of Knoll Pharmaceutical Company, and were intricately involved in the marketing and clinical development of the Vicodin® franchise, Vicoprofen®, and Dilaudid®, as well as providing evaluations of narcotic and non-narcotic analgesic in-licensing candidates.

They also designed and executed all the market research and strategic plans for D2E7, a TNF-inhibitor in development for rheumatoid arthritis. And they have evaluated licensing opportunities in the NSAID category and products designed to improve the performance of existing opioids.